Chinese Academy of Medical Sciences
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2021-02-01
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 350
- Registration Number
- NCT04500145
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring
- Conditions
- Interventions
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 75
- Registration Number
- NCT04499794
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL
- Conditions
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 407
- Registration Number
- NCT04491721
- Locations
- 🇨🇳
Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Comparison of Two Bending Angles for Nasotracheal Intubation With a Malleable Vedio Stylet
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 98
- Registration Number
- NCT04459481
- Locations
- 🇨🇳
ChineseAMS, Beijing, Beijing, China
Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT04452370
- Locations
- 🇨🇳
Cancer Institute & Hospital. Chinese Academy of Medical Sciences, Beijing, China
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2020-06-25
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT04447274
Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-06-18
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 286
- Registration Number
- NCT04437160
- Locations
- 🇨🇳
Cancer Hospital & Institute Chinese Academy of Medical Sciences (CAMS), Beijing, Beijing, China
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT04425824
- Locations
- 🇨🇳
Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2020-05-18
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 70
- Registration Number
- NCT04390958
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 106
- Registration Number
- NCT04380103
- Locations
- 🇨🇳
National Center/Cancer Hospital, China Academy of Medical Science and Peking Union Medical College, Beijing, China
🇨🇳National Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China